GlassScriptPhysician profile
Priya N Oolut
NPI 1013144690
$236,240.05
in general payments reported to CMS, 2019-2025
55 companies · $8,950 in 2025
The $8,950 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,475 · 2020: $11K · 2021: $22K · 2022: $26K · 2023: $103K · 2024: $63K · 2025: $8,950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $159K · Food and Beverage: $7,866 · Education: $5,611 · Travel and Lodging: $1,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $159,387.50 |
| Food and Beverage | $7,865.59 |
| Education | $5,610.85 |
| Travel and Lodging | $1,739.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $217,405.35 | 2019-2025 | Arexvy, Nucala, Trelegy Ellipta |
| Intuitive Surgical, INC. | $6,522.95 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,696.60 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Genzyme Corporation | $915.97 | 2019-2025 | |
| Electromed, INC. | $853.82 | 2019-2025 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $784.12 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $777.51 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Harmony Biosciences LLC | $743.43 | 2020-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $654.80 | 2019-2024 | Dupixent |
| Philips North America LLC | $451.34 | 2019-2025 | (Ak6) Vest Therapy, Home Pi Undivided, Vest Therapy Und |
| Mallinckrodt Hospital Products INC. | $356.71 | 2021-2025 | Acthar |
| Amgen INC. | $342.64 | 2022-2025 | Tezspire |
| Mylan Specialty L.P. | $336.94 | 2019-2024 | Yupelri |
| Optinose US, INC. | $318.65 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $304.97 | 2020-2024 | Xarelto |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $303.21 | 2019-2025 | Arikayce |
| Jazz Pharmaceuticals INC. | $271.56 | 2019-2024 | |
| Grifols USA, LLC | $266.26 | 2019-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $262.71 | 2020-2025 | Aralast, Glassia |
| United Therapeutics Corporation | $236.72 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Pfizer INC. | $178.97 | 2019-2025 | |
| Watermark Medical, INC. | $175.19 | 2020-2021 | |
| Abbvie INC. | $166.22 | 2022-2025 | |
| Inogen, INC. | $162.05 | 2020-2025 | Inogen One G3 Oxygen Concentrator, Inogen One G5 Oxygen Concentrator - Bluetooth |
| Avadel Cns Pharmaceuticals, LLC | $143.38 | 2023-2025 | Lumryz |
| Merck Sharp & Dohme LLC | $117.30 | 2022-2025 | Winrevair |
| Ani Pharmaceuticals, INC. | $114.56 | 2024-2025 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $101.78 | 2019-2024 | |
| Viatris Specialty LLC | $92.13 | 2025 | Yupelri |
| Verona Pharma, INC. | $88.38 | 2025 | Ohtuvayre |
| Sanofi US Services INC. | $76.16 | 2024-2025 | |
| Genentech USA, INC. | $74.21 | 2019 | |
| Inspire Medical Systems, INC. | $73.05 | 2024-2025 | Inspire |
| Shionogi INC | $72.39 | 2021-2022 | |
| Resmed Corp | $71.86 | 2022-2025 | |
| Circassia INC. | $64.97 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $63.76 | 2022-2023 | |
| Vifor Pharma, INC. | $61.55 | 2025 | Veltassa |
| Pulmonx Corporation | $56.10 | 2023-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Allergan, INC. | $54.00 | 2019 | |
| Sunovion Pharmaceuticals INC. | $48.19 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $47.65 | 2021 | |
| Sanofi Pasteur INC. | $37.79 | 2019 | |
| Lilly USA, LLC | $37.69 | 2025 | Zepbound, Mounjaro |
| Ethicon INC. | $36.78 | 2025 | Monarch Platform |
| Gilead Sciences, INC. | $34.49 | 2019 | |
| Tactile Systems Technology INC | $30.60 | 2023 | Flexitouch Plus, Entre Plus |
| Baxter Healthcare | $28.42 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Axsome Therapeutics, INC. | $24.93 | 2023 | Sunosi |
| 3b Medical, INC. | $24.46 | 2025 | Luna |
| Nabriva Therapeutics, Plc | $22.86 | 2020 | |
| Biogen, INC. | $21.97 | 2023 | Spinraza |
| Phadia US INC. | $14.63 | 2025 | Immunocap |
| Fisher & Paykel Healthcare INC | $11.12 | 2019 | |
| Veran Medical Technologies, INC. | $4.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Oolut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.